This inventor holds 2 USPTO granted patents. Top assignees: H. Lee Moffitt Cancer Center, Research Institute, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 2 Years Active: 2026
Title: Glen Barber: Inventor in Cancer Research
Introduction
Glen Barber is an inventor associated with Miami, Florida, and the H. Lee Moffitt Cancer Center and Research Institute. His patent work includes an approach to strengthening antitumor immune responses in melanoma with impaired STING signaling.
Latest Patents
Barber’s listed patent portfolio includes 2 patents. One of his latest patents, “Enhancing Anti-Tumor Response in Melanoma Cells with Defective STING Signaling,” describes methods for improving antitumor T-cell responses. The disclosed approach uses a demethylating agent to address deficient STING expression in tumor cells.
The patent also describes identifying reduced STING or cGAS expression in a biopsy sample before treatment. Additional treatment options may include a STING agonist or tumor-infiltrating lymphocytes, including HLA-matched TILs.
Career Highlights
Barber’s listed affiliation with the H. Lee Moffitt Cancer Center and Research Institute connects his work to cancer research and potential immunotherapy applications. The patent focuses on strategies for tumors in which STING signaling is defective.
Collaborations
Barber’s listed coworkers include James Mulé and Rana Falahat. Their names are associated with his professional and research context.
Conclusion
Glen Barber’s patent work addresses a targeted immunotherapy strategy for melanoma, combining biomarker assessment with approaches intended to enhance antitumor immune responses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile